TY  - GEN
AU  - Su,Yongwei
AU  - Li,Xinyu
AU  - Ma,Jun
AU  - Zhao,Jianyun
AU  - Liu,Shuang
AU  - Wang,Guan
AU  - Edwards,Holly
AU  - Taub,Jeffrey W
AU  - Lin,Hai
AU  - Ge,Yubin
TI  - Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo
SN  - 1873-2968
PY  - 2018///1217
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - pharmacology
KW  - Cell Line, Tumor
KW  - Cell Survival
KW  - drug effects
KW  - Child
KW  - Child, Preschool
KW  - Drug Delivery Systems
KW  - Extracellular Signal-Regulated MAP Kinases
KW  - genetics
KW  - Female
KW  - Gene Expression Regulation
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Male
KW  - Metabolic Networks and Pathways
KW  - Middle Aged
KW  - Phosphatidylinositol 3-Kinases
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - TOR Serine-Threonine Kinases
KW  - Up-Regulation
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.bcp.2017.11.022
ER  -